These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 17635376

  • 1. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
    Lees CW, Heys D, Ho GT, Noble CL, Shand AG, Mowat C, Boulton-Jones R, Williams A, Church N, Satsangi J, Arnott ID, Scottish Society of Gastroenterology Infliximab Group.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):411-9. PubMed ID: 17635376
    [Abstract] [Full Text] [Related]

  • 2. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R.
    Dig Liver Dis; 2008 Oct 01; 40(10):821-6. PubMed ID: 18472316
    [Abstract] [Full Text] [Related]

  • 3. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK, Uzcanga LF.
    Dig Surg; 2008 Oct 01; 25(5):383-6. PubMed ID: 19005257
    [Abstract] [Full Text] [Related]

  • 4. Outcome of a conservative approach in severe ulcerative colitis.
    Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, Pera A.
    Dig Liver Dis; 2004 Jan 01; 36(1):21-8. PubMed ID: 14971812
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Masuda S, Inui K, Chiba T.
    J Gastroenterol Hepatol; 2010 May 01; 25(5):886-91. PubMed ID: 20546441
    [Abstract] [Full Text] [Related]

  • 6. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL, Jewell DP, Travis SP.
    Aliment Pharmacol Ther; 2007 May 01; 25(9):1055-60. PubMed ID: 17439506
    [Abstract] [Full Text] [Related]

  • 7. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
    Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Viscido A, Annese V, Riegler G, Meucci G, Marrollo M, Sostegni R, Gasbarrini A, Peralta S, Prantera C.
    Aliment Pharmacol Ther; 2007 Sep 01; 26(5):747-56. PubMed ID: 17697208
    [Abstract] [Full Text] [Related]

  • 8. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
    Russo EA, Harris AW, Campbell S, Lindsay J, Hart A, Arebi N, Milestone A, Tsai HH, Walters J, Carpani M, Westaby D, Thillainayagam A, Bansi D, Ghosh S.
    Aliment Pharmacol Ther; 2009 Feb 01; 29(3):308-14. PubMed ID: 19035973
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
    Maser EA, Deconda D, Lichtiger S, Ullman T, Present DH, Kornbluth A.
    Clin Gastroenterol Hepatol; 2008 Oct 01; 6(10):1112-6. PubMed ID: 18928936
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
    Croft A, Walsh A, Doecke J, Cooley R, Howlett M, Radford-Smith G.
    Aliment Pharmacol Ther; 2013 Aug 01; 38(3):294-302. PubMed ID: 23786158
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.
    Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, Stein RB, Adler DR, Lichtenstein GR.
    Am J Gastroenterol; 2002 Oct 01; 97(10):2577-84. PubMed ID: 12385442
    [Abstract] [Full Text] [Related]

  • 12. Management of acute severe ulcerative colitis.
    Van Assche G, Vermeire S, Rutgeerts P.
    Gut; 2011 Jan 01; 60(1):130-3. PubMed ID: 21030524
    [Abstract] [Full Text] [Related]

  • 13. Infliximab in the treatment of severe ulcerative colitis: a follow-up study.
    Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M.
    Eur Rev Med Pharmacol Sci; 2004 Jan 01; 8(5):235-7. PubMed ID: 15638237
    [Abstract] [Full Text] [Related]

  • 14. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F, Orlando A, Scimeca D, Cottone M.
    Recenti Prog Med; 2007 Nov 01; 98(11):560-4. PubMed ID: 18044405
    [Abstract] [Full Text] [Related]

  • 15. A review of infliximab use in ulcerative colitis.
    Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.
    Clin Ther; 2008 Feb 01; 30(2):223-30. PubMed ID: 18343261
    [Abstract] [Full Text] [Related]

  • 16. Infliximab for ulcerative colitis in children and adolescents.
    McGinnis JK, Murray KF.
    J Clin Gastroenterol; 2008 Sep 01; 42(8):875-9. PubMed ID: 18645529
    [Abstract] [Full Text] [Related]

  • 17. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A.
    Eur Rev Med Pharmacol Sci; 2004 Sep 01; 8(5):231-3. PubMed ID: 15638236
    [Abstract] [Full Text] [Related]

  • 18. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.
    Herrlinger KR, Barthel DN, Schmidt KJ, Büning J, Barthel CS, Wehkamp J, Stange EF, Fellermann K.
    Aliment Pharmacol Ther; 2010 May 01; 31(9):1036-41. PubMed ID: 20175769
    [Abstract] [Full Text] [Related]

  • 19. Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital.
    Seiderer J, Göke B, Ochsenkühn T.
    Digestion; 2004 May 01; 70(1):3-9. PubMed ID: 15297773
    [Abstract] [Full Text] [Related]

  • 20. Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
    Jürgens M, Laubender RP, Hartl F, Weidinger M, Seiderer J, Wagner J, Wetzke M, Beigel F, Pfennig S, Stallhofer J, Schnitzler F, Tillack C, Lohse P, Göke B, Glas J, Ochsenkühn T, Brand S.
    Am J Gastroenterol; 2010 Aug 01; 105(8):1811-9. PubMed ID: 20197757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.